Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Lieberman

Showing results (31-40 of 246) with videos related to

Pageof 25
Sort By:
Schizophrenia Bulletin|January 1, 1993
Neurochemistry and neuroendocrinology of schizophrenia: a selective reviewJ A Lieberman, A R Koreen
Journal of Clinical Psychopharmacology|April 1, 1994
A reevaluation of the clinical characteristics of clozapine-induced agranulocytosis in light of the United States experienceJ M Alvir, J A Lieberman
New York State Journal of Medicine|December 1, 1980
Clinical utility of tricyclic blood levelsJ A Lieberman, R A O'Connell
The American Journal of Psychiatry|February 17, 1998
Medical complications and selectivity of therapeutic response to atypical antipsychotic drugsD O Perkins, J A Lieberman
The Psychiatric Quarterly|January 1, 1992
Clinical profile of clozapine: adverse reactions and agranulocytosisJ A Lieberman, A Z Safferman
Physician Executive|January 7, 1997
Health care fraud and abuse. What physician executives need to knowK M Nelson, J A Lieberman
The Psychiatric Clinics of North America|June 1, 1993
Schizophrenia and substance abuseJ A Selzer, J A Lieberman
Drug Safety|January 1, 1992
A report of clozapine-induced agranulocytosis in the United States. Incidence and risk factorsJ A Lieberman, J M Alvir
Psychopharmacology|March 1, 1996
Mechanisms of action of atypical antipsychotic drugs: a critical analysisB J Kinon, J A Lieberman
The American Journal of Psychiatry|November 1, 1996
Redefining the role of psychiatry in medicineJ A Lieberman, A J Rush
Pageof 25

Showing results (31-40 of 246) with videos related to

Sort By:
Pageof 25
Schizophrenia Bulletin|January 1, 1993
Neurochemistry and neuroendocrinology of schizophrenia: a selective reviewJ A Lieberman, A R Koreen
Journal of Clinical Psychopharmacology|April 1, 1994
A reevaluation of the clinical characteristics of clozapine-induced agranulocytosis in light of the United States experienceJ M Alvir, J A Lieberman
New York State Journal of Medicine|December 1, 1980
Clinical utility of tricyclic blood levelsJ A Lieberman, R A O'Connell
The American Journal of Psychiatry|February 17, 1998
Medical complications and selectivity of therapeutic response to atypical antipsychotic drugsD O Perkins, J A Lieberman
The Psychiatric Quarterly|January 1, 1992
Clinical profile of clozapine: adverse reactions and agranulocytosisJ A Lieberman, A Z Safferman
Physician Executive|January 7, 1997
Health care fraud and abuse. What physician executives need to knowK M Nelson, J A Lieberman
The Psychiatric Clinics of North America|June 1, 1993
Schizophrenia and substance abuseJ A Selzer, J A Lieberman
Drug Safety|January 1, 1992
A report of clozapine-induced agranulocytosis in the United States. Incidence and risk factorsJ A Lieberman, J M Alvir
Psychopharmacology|March 1, 1996
Mechanisms of action of atypical antipsychotic drugs: a critical analysisB J Kinon, J A Lieberman
The American Journal of Psychiatry|November 1, 1996
Redefining the role of psychiatry in medicineJ A Lieberman, A J Rush
Pageof 25